Tacrolimus Induced Diabetic Ketoacidosis Following Hematopoietic Stem Cell Transplantation.
Indian J Hematol Blood Transfus
; 35(4): 711-713, 2019 Oct.
Article
em En
| MEDLINE
| ID: mdl-31741624
ABSTRACT
Risk of diabetes mellitus increases after solid organ and hematopoietic stem cell transplantation. Diabetic ketoacidosis has been reported after solid organ transplantation in patients receiving tacrolimus but has rarely been reported after stem cell transplantation. The major risk factors for diabetic ketoacidosis are immunosuppressive drugs used after transplantation. We report here three cases of allogenic stem cell transplant who developed diabetic ketoacidosis while on treatment with tacrolimus. The drug was stopped in all the cases and patients were treated with insulin therapy resulting in complete recovery from diabetic ketoacidosis.
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Revista:
Indian J Hematol Blood Transfus
Ano de publicação:
2019
Tipo de documento:
Article